1,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?
Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Diana
D
Ovejero
Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Rachel I
RI
Gafni
Section on Skeletal Disorders and Mineral Homeostasis, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Michael T
MT
Collins
D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol; D053098:Familial Hypophosphatemic Rickets; D006801:Humans; D007015:Hypophosphatemia, Familial; D010710:Phosphates; D014807:Vitamin D / Q000031:analogs & derivatives
D010710:Phosphates; D014807:Vitamin D; D015650:24,25-Dihydroxyvitamin D 3; C097949:1,25-dihydroxyvitamin D; D002117:Calcitriol